Literature DB >> 20140422

Surgical therapies of female stress urinary incontinence: experience in 228 cases.

Jin-Yan Wu1, Hong-Chao He, Shan-Wen Chen, Xiao-Dong Jin, Yun-Xiao Zhou.   

Abstract

INTRODUCTION AND HYPOTHESIS: The objective of this study is to compare the efficacy and safety of tension-free vaginal tape (TVT) with Marshall-Marchetti-Krantz (MMK) procedure in stress urinary incontinence (SUI) treatment.
METHODS: Two hundred twenty-eight patients were enrolled in this study. TVT procedure was performed in 105 cases, MMK procedure was performed in 81 cases, Chi-square test was used, and P < 0.01 was considered statistically significant.
RESULTS: The short-term success rate was about 89% in MMK group. However, the success rate fell to 68.2% at 5 years and 32% at 10 years. The short-term cure rate of TVT procedure was about 90.0%, and the 5-year cure rate was 84.3%.
CONCLUSIONS: The short-term cure rate in both groups was similar, but the long-term success rate of the MMK procedure decreased sharply with time. The TVT technique provides long-term cure rates of over 84% with minimal complications. Patients who underwent TVT experienced shorter operation time, less blood loss, and less hospital stay.

Entities:  

Mesh:

Year:  2010        PMID: 20140422     DOI: 10.1007/s00192-009-1093-5

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  16 in total

Review 1.  A systematic review of tension-free urethropexy for stress urinary incontinence: intravaginal slingplasty and the tension-free vaginal tape procedures.

Authors:  T Merlin; E Arnold; P Petros; P MacTaggart; A Tulloch; K Faulkner; G Maddern
Journal:  BJU Int       Date:  2001-12       Impact factor: 5.588

2.  Procedures for pelvic organ prolapse in the United States, 1979-1997.

Authors:  Sarah Hamilton Boyles; Anne M Weber; Leslie Meyn
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

3.  Stress urinary incontinence surgery in the United States.

Authors:  L Elaine Waetjen; Leslee L Subak; Hui Shen; Feng Lin; Tsung-Hsi Wang; Eric Vittinghoff; Jeanette S Brown
Journal:  Obstet Gynecol       Date:  2003-04       Impact factor: 7.661

4.  The demographics of pelvic floor disorders: current observations and future projections.

Authors:  K M Luber; S Boero; J Y Choe
Journal:  Am J Obstet Gynecol       Date:  2001-06       Impact factor: 8.661

Review 5.  Surgery for genuine stress incontinence.

Authors:  G J Jarvis
Journal:  Br J Obstet Gynaecol       Date:  1994-05

6.  Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence.

Authors:  C G Nilsson; N Kuuva; C Falconer; M Rezapour; U Ulmsten
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

7.  Burch colposuspension versus modified Marshall-Marchetti-Krantz urethropexy for primary genuine stress urinary incontinence: a prospective, randomized clinical trial.

Authors:  M Colombo; S Scalambrino; A Maggioni; R Milani
Journal:  Am J Obstet Gynecol       Date:  1994-12       Impact factor: 8.661

8.  Long-term subjective results of Marshall-Marchetti-Krantz procedure.

Authors:  M Czaplicki; P Dobroński; C Torz; A Borkowski
Journal:  Eur Urol       Date:  1998-08       Impact factor: 20.096

9.  Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence.

Authors:  U Ulmsten; P Petros
Journal:  Scand J Urol Nephrol       Date:  1995-03

10.  Long-term results of the Stamey bladder neck suspension: direct comparison with the Marshall-Marchetti-Krantz procedure.

Authors:  J Q Clemens; J A Stern; W A Bushman; A J Schaeffer
Journal:  J Urol       Date:  1998-08       Impact factor: 7.450

View more
  1 in total

Review 1.  Safety considerations for synthetic sling surgery.

Authors:  Jerry G Blaivas; Rajveer S Purohit; Matthew S Benedon; Gabriel Mekel; Michael Stern; Mubashir Billah; Kola Olugbade; Robert Bendavid; Vladimir Iakovlev
Journal:  Nat Rev Urol       Date:  2015-08-18       Impact factor: 14.432

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.